» Articles » PMID: 17382765

Multivariate Analysis of Factors Predicting Success with Dextranomer/hyaluronic Acid Injection for Vesicoureteral Reflux

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2007 Mar 27
PMID 17382765
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Factors influencing outcomes of dextranomer/hyaluronic acid injection for vesicoureteral reflux remain poorly defined. We performed multivariate analysis of the experience of 1 surgeon (WS).

Materials And Methods: The study group contained 168 patients and 259 refluxing units. Goal of injection was coaptation of the orifice with creation of a volcanic mound. Outcomes were determined by cystography obtained 12 weeks following injection. Intraoperative photographs of mounds were independently reviewed by 2 authors (WS, SY) without knowledge of results, and classified as "satisfactory" or "other." Univariate and multivariate logistic regression analysis was done evaluating influence of gender, age, voiding dysfunction, reflux grade, unilateral vs bilateral reflux, ureteral duplication, orifice laterality, subureteral vs intraureteral injection, volume injected and mound appearance.

Results: A single injection resolved reflux in 70% of patients and 78% of ureters. Additional injection resulted in overall success in 82% of patients and 86% of ureters. Multivariate analysis demonstrated that reflux grade, volume of dextranomer/hyaluronic acid injected and mound appearance correlated with outcomes. A satisfactory mound was achieved in 81% of ureters, of which 87% no longer refluxed.

Conclusions: The ability to create a satisfactory mound was the most important factor determining success of dextranomer/hyaluronic acid injection. Increasing reflux grade was associated with a decreased likelihood of achieving a volcanic mound, and increasing volume injected suggested difficulty in creating a mound.

Citing Articles

Primary vesicoureteral reflux.

Puri P, Friedmacher F, Farrugia M, Sharma S, Esposito C, Mattoo T Nat Rev Dis Primers. 2024; 10(1):75.

PMID: 39389958 DOI: 10.1038/s41572-024-00560-8.


Predictors of reflux persistence after endoscopic dextranomer/hyaluronic Acid copolymer injection in pediatric patients with Vesicoureteral reflux: short-term results.

Yilmaz I, Akdogan N, Deger M, Aridogan I, Izol V, Satar N Sci Rep. 2024; 14(1):15252.

PMID: 38956126 PMC: 11219909. DOI: 10.1038/s41598-024-62449-6.


Endoscopic injection of bulking agents in pediatric vesicoureteral reflux: a narrative review of the literature.

Escolino M, Kalfa N, Castagnetti M, Caione P, Esposito G, Florio L Pediatr Surg Int. 2023; 39(1):133.

PMID: 36806763 PMC: 9938816. DOI: 10.1007/s00383-023-05426-w.


Modified unilateral periureteral injection technique in the treatment of patients with high-grade vesicoureteral reflux: A study of primary findings.

Asgari S, Safaei-Asl A, Mansour-Ghanaie M, Asgari S, Faryabi A, Bazli M Asian J Urol. 2023; 10(1):96-100.

PMID: 36721703 PMC: 9875151. DOI: 10.1016/j.ajur.2021.11.011.


Antireflux endoscopic injection therapy in post-pubertal patients via techniques adopted for the dilated ureteral orifice: a retrospective single-center study.

Maruyama T, Mizuno K, Nishio H, Kato T, Hamakawa T, Ikegami Y BMC Urol. 2021; 21(1):70.

PMID: 33894751 PMC: 8067324. DOI: 10.1186/s12894-021-00842-3.